RNWL
INTERNATIONAL REGISTRATION RENEWED
05/28/2026
Back to search
Official data from USPTO
LENICURA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
05/29/2026
Trademark type
Combined
Nice classes
10, 37, 44
Filing date
05/23/2016
Registration date
09/12/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/24/2024
Last transaction
05/29/2026
Responsible office
United States Patent and Trademark Office
Status code
707
Official register
Principal Register
Drawing code
3
Owner type
27
Owner location
Wiesbaden, DE
Examiner
LUDEMAN, JESSICA ANN
Law office
L40
Current location
FILE DESTROYED
Mark description
The mark consists of two blue curved polygons, shaded in turquoise, that are side by side and above the wording "LENICURA" in black. The color white is merely for background and is not claimed as a feature of the mark.
Holders and representatives
Holders
LENICURA GmbH
LENICURA GmbH
Representatives
Steven Walmsley REISING ETHINGTON PC
Technical classification
Nice Classes
Class 10Class 37Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Medical apparatus and instruments for the use in treatment of inflammatory diseases of the skinthe glandsthe mucous membranesthe connective tissuethe nerves and the horn tissue and for the use in treatment of hidradenitis suppurativaacne inversaabscesses and acne; medical radiation apparatus; electromagnetic wave therapeutic medical instruments for the use in treatment of inflammatory diseases of the skinthe glandsthe mucous membranesthe connective tissuethe nerves and the horn tissue and for the use in treatment of hidradenitis suppurativaacne inversaabscesses and acne; visible light treatment medical instruments for the use treatment of inflammatory diseases of the skinthe glandsthe mucous membranesthe connective tissuethe nerves and the horn tissue and for the use in treatment of hidradenitis suppurativaacne inversaabscesses and acne; medical skin enhancement apparatus and instruments for the use in treatment of inflammatory diseases of the skinthe glandsthe mucous membranesthe connective tissuethe nerves and the horn tissue and for the use in treatment of hidradenitis suppurativaacne inversaabscesses and acne; medical apparatus and instruments for the treatment of diseases of the skinthe glandsthe mucous membranesthe connective tissuethe nerves and the horn tissue; medical apparatus and instruments for the treatment of hidradenitis suppurativa and acne inversa
Class 37
Repair and maintenance of medical machinesapparatus and instruments
Class 44
Medical treatment services of inflammatory diseases of the skinthe glandsthe mucous membranesthe connective tissuethe nerves and the horn tissue and for the use in treatment of hidradenitis suppurativaacne inversaabscesses and acne; cosmetic treatment for the body; medical treatment of the skin; dermatological services for treating skin conditions; medical testing services relating to the diagnosis and treatment of disease; arranging of medical treatmentconsulting services in the field of health; cosmetic treatmentproviding facial and body treatment servicescosmetic body care services; medical services in the nature of therapeutic treatment of the skinthe glandsthe mucous membranesthe connective tissuethe nerves and the horn tissue; medical services in the nature of therapeutic treatment of hidradenitis suppurativa and acne inversa
Publications
History of USPTO decisions and trademark events.
39 publications found
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
05/03/2025
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
04/13/2025
INPC
INVALIDATION PROCESSED
04/12/2025
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
01/24/2025
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
05/24/2024
71.P
REGISTERED - PARTIAL SEC 71 ACCEPTED
05/24/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/06/2024
ES71
TEAS SECTION 71 RECEIVED
09/07/2023
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
09/12/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/02/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/18/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/24/2018
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/26/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/19/2017
FIMP
FINAL DISPOSITION PROCESSED
12/19/2017
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/12/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
09/12/2017
PUBO
PUBLISHED FOR OPPOSITION
06/27/2017
NPUB
NOTICE OF PUBLICATION
06/07/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/19/2017
CNEA
EXAMINERS AMENDMENT MAILED
05/19/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/19/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
05/19/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/19/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/02/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/02/2017
ALIE
ASSIGNED TO LIE
05/01/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/11/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/10/2017
RFNT
REFUSAL PROCESSED BY IB
10/28/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/13/2016
RFRR
REFUSAL PROCESSED BY MPU
10/13/2016
MAFR
APPLICATION FILING RECEIPT MAILED
10/07/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/05/2016
CNRT
NON-FINAL ACTION WRITTEN
10/04/2016
DOCK
ASSIGNED TO EXAMINER
10/03/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/03/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/01/2016
Continuous trademark protection
Get notified about every new filing that threatens LENICURA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.